newsfilter
← Latest News
PR Newswire·

Acasti to Participate in the Lytham Partners Spring 2023 Investor Conference

LAVAL, QC, May 17, 2023 /PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses